Serena Williams remains at the center of a swirling debate despite taking steps that hint at a potential return to tennis, only to insist she won’t rejoin the competition. The American icon, who captured 23 Grand Slam singles titles, stepped away following the 2022 US Open, but recent activity suggests otherwise.
The International Tennis Integrity Agency (ITIA) has confirmed to BBC Sport that Williams is once again listed among players registered for the sport’s drug testing pool. Her name appears on the latest ITIA document published on 6 October, indicating that she is indeed back in the testing radar. Yet mere hours after this disclosure, Williams posted on social media declaring, “I’m NOT coming back. This wildfire is crazy.” The contradiction between re-entry into drug testing and a firm statement of non-return leaves observers puzzled about the motives behind resuming testing eligibility without intent to compete.
The reason behind adding her name to the pool while signaling an intentional non-return remains unclear. Participation in the pool obligates out-of-competition testing, which could be a prerequisite for any future activity but also raises questions about timing and purpose.
Williams has long resisted the label of retirement, preferring the idea of “evolving away” from the sport since 2022. Her presence at the US Open three years ago drew a high-profile crowd that included Bill Clinton, Billie Jean King, Tiger Woods, and Mike Tyson, as she secured her first two singles wins in New York.
Ultimately, Williams’ professional farewell came at the hands of Australia’s Ajla Tomljanović in the third round, a match capped by an unforgettable night session at Arthur Ashe Stadium where Williams fought off five match points to keep her pursuit alive.
In tennis, every retiree must remain available for out-of-competition testing for six months before resuming competition at the professional level. It isn’t clear when Williams requested re-entry to the testing pool; even if the six-month clock began on 6 October, a potential comeback could theoretically be possible from April of the following year.
Among all-time greats, only Margaret Court and Novak Djokovic have amassed more Grand Slam singles titles than Williams. Her record includes seven Australian Open titles, three French Opens, seven Wimbledon championships, and six US Opens—the most major singles titles won by a woman in the Open Era.
The Williams sisters’ on-court collaboration has also left a lasting imprint. Venus Williams made a notable comeback earlier this year after a 16-month hiatus, competing in both singles and doubles at the US Open and reaching the doubles quarterfinals with Leylah Fernandez. The prospect of a Williams sisters reunion in 2026 remains a tantalizing possibility for fans and analysts alike, given their storied history of dominance and partnership in doubles, where they captured 14 Grand Slam doubles titles and two Olympic golds.
As discussions continue, the tennis world watches closely for any official developments that might confirm a return or reinforce Williams’s current stance. The larger question remains: if she does come back, what form would that return take, and how would it reshape the landscape of contemporary women’s tennis?
